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In situ formation of 
magnetopolymersomes via 
electroporation for MRI
Jennifer Bain1, Lorena Ruiz-Pérez2,3,4, Aneurin J. Kennerley5, Stephen P. Muench6, 
Rebecca Thompson6, Giuseppe Battaglia2,3,4 & Sarah S. Staniland1
As the development of diagnostic/therapeutic (and combined: theranostic) nanomedicine grows, 
smart drug-delivery vehicles become ever more critical. Currently therapies consist of drugs tethered 
to, or encapsulated within nanoparticles or vesicles. There is growing interest in functionalising 
them with magnetic nanoparticles (MNPs) to target the therapeutics by localising them using 
magnetic fields. An alternating magnetic field induces remote heating of the particles (hyperthermia) 
triggering drug release or cell death. Furthermore, MNPs are diagnostic MRI contrast agents. There 
is considerable interest in MNP embedded vehicles for nanomedicine, but their development is 
hindered by difficulties producing consistently monodisperse MNPs and their reliable loading into 
vesicles. Furthermore, it is highly advantageous to "trigger" MNP production and to tune the MNP's 
size and magnetic response. Here we present the first example of a tuneable, switchable magnetic 
delivery vehicle for nanomedical application. These are comprised of robust, tailored polymer vesicles 
(polymersomes) embedded with superparamagnetic magnetite MNPs (magnetopolymersomes) 
which show good MRI contrast (R2* = 148.8 s−1) and have a vacant core for loading of therapeutics. 
Critically, the magnetopolymersomes are produced by a pioneering nanoreactor method whereby 
electroporation triggers the in situ formation of MNPs within the vesicle membrane, offering a 
switchable, tuneable magnetic responsive theranostic delivery vehicle.
Natural lipids (e.g. phospholipids) self-assemble to form biological membranes and vesicles (liposomes) 
and as such are traditionally employed in the formation of biocompatible vesicles for medical applica-
tions1. However phospholipids can prove restrictive and unstable with respect to responsive functional-
ization limiting their use in new smart nanomedical materials. More recently, amphiphilic copolymers 
have been utilized as lipid mimics. Their self-assembly into “polymersomes” (polymer vesicles) under 
a range of chemical conditions offers a more robust and flexible system with greater scope for modifi-
cations both pre and post formation. This, in combination with the intrinsic improvement of the final 
robust mechanical properties, makes polymersomes ideal drug delivery and diagnostic agents2,3.
The applicability of a therapeutic or diagnostic agent can be dramatically enhanced by the addition 
of magnetic functionality, achieved by incorporation of magnetic nanoparticles (MNPs). Post formation 
loading of MNPs into a range of vesicles and particles is of rapid growing interest for use in a range of 
targeted medical treatments4–9. MNP incorporation into vesicles can be localized and concentrated to a 
specific site using a large magnetic field10, making magnetic vesicles ideal targeted drug-delivery vehi-
cles11–14. They can be engineered to release cargo at a specific treatment site, allowing for lower therapeu-
tic doses which significantly improves treatment efficiency, whilst simultaneously reducing overall dose 
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and side effects15. Magnetized vesicles are also valuable contrast agents in existing diagnostic techniques 
such as MRI imaging, as their local magnetic field dramatically increases the local atomic relaxation 
time, resulting in darkening of this area of the image. Furthermore, the magnetism can be exploited for 
therapeutic magnetic hyperthermia treatments, in which MNPs exposed to a time varying magnetic field 
gives rise to magnetically induced heating, and the subsequent destruction of surrounding tissue and/
or release of heat activated drugs, which have the potential for both conjugation to the polymersome 
exterior or to be encapsulated within the vesicle core10,16,17. All these elements can also be combined to 
give a multipurpose “theranostic” nanomedicine. The amount of heat generated (hyperthermia), and 
the degree of contrast achieved (MRI) is highly dependent on MNP characteristics such as the size and 
concentration of the particles10,18.
It is clear that the combination of a robust, modifiable polymersome with the magnetic response of 
MNPs could form an ideal theranostic delivery agent for nanomedicine. Encapsulated MNPs within 
polymer supported liposomes and polymersomes have recently been investigated for both drug deliv-
ery19 and for theranostic nanomedicine9, respectively. However, loading of MNPs into the vesicle core 
along with therapeutics, results in adverse effects such as simultaneous release of MNPs and drugs. 
Furthermore, the magnetopolymersomes developed to date rely on a multistep process of crystallising 
and processing MNPs, then subsequent loading into polymer vesicles9,19. For this crystallisation step, 
iron-oxide MNPs can be produced by various methods leading to differing size, shape and population 
heterogeneity18. The simplest route to magnetite MNPs is a room temperature co-precipitation, whereby 
MNPs are precipitated by raising the pH of a mixed valence iron solution with base (e.g. NaOH) under 
an inert atmosphere. However, in the absence of any additives or templates, the resulting MNPs are of 
a broad range of shapes and sizes and commonly contain a range of other iron-oxide contaminants. 
Mixed populations require labour-intensive sorting before they are suitable for loading into the vesicles9. 
Other methods produce more mono-disperse populations, but require additional additives, toxic and/
or organic (non-biocompatible) solvents /reagents and high temperatures, resulting in costly, multistep 
processes18. Consequently, current magnetopolymersomes are not ideal with respect to easy synthesis 
and the challenge remains to create a magnetopolymersome with: mono-disperse MNPs embedded in 
the membrane, leaving the core free for therapeutic agents to be released; via a simple method involving 
mild conditions that offers precise control over MNP size and concentration. We overcome the issues 
outlined above and achieve this goal by using electroporation to initiate in situ production of magne-
topolymersomes with a mono-disperse population of MNPs within its polymersome membrane.
More generally, electroporation uses an electric field to open temporary hydrophilic nanoscopic pores 
in a cell or vesicle membrane allowing reagents to cross the membrane20–23. The potential generated 
across the membrane is dependent on the membrane composition, cell size, and extracellular medium20. 
Until recently electroporation has only been used to open pores in lipid membranes to allow the inser-
tion of biomolecules into biological cells, (e.g. insertion of DNA into host cells)21.
Recently we reported the first use of electroporation to open pores in polymer membranes to load pol-
ymersomes with nucleic acids and proteins post vesicle formation, proving that polymer membranes can-
not only withstand electrical stress but are also able to undergo electroporation, and remain functional22.
Here we report a completely new synthetic method of magnetising vesicles using electroporation, 
marking a novel and previously unreported use of this technique. Polymersomes with a high pH aqueous 
core are suspended in an iron solution with the membrane providing a reaction barrier. We propose a 
mechanism whereby upon electroporation, pores open allowing synthetic ion-transport across the poly-
mer membrane, resulting in an iron ion/base interface within the poration channels. The membrane acts 
as a nucleation site and the pore acts as a template to restrict the size of the growing MNPs within the 
membrane (Fig.  1). We have, for the first time applied electroporation to initiate a nanoreactor chem-
ical precipitation of inorganic reagents; offering greater templated control in an easy, one-step process. 
Control of the electroporation parameters can control pore size and thus iron flow, regulating MNP size, 
resulting in the advantage of magnetically tuneable magnetopolymersomes. Furthermore, the in situ 
Figure 1. Schematic of the proposed mechanism for MNP synthesis within polymersomes using 
electroporation (a), which opens pores within the membrane at which point influx of iron ions occurs in 
parallel with efflux of NaOH (encapsulated) (b). (c) shows the in situ room temperature co-precipitation that 
then occurs at the interface within the membrane.
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electroporation process offers a switchable magnetic response activated by an electric field. In this study, 
polymersomes encapsulating OH− ions are electroporated in the presence of mixed valence iron salts. 
Electroporation allows the permeation of reagents, resulting in in situ crystallization of MNPs within 
the polymersome membrane yielding magnetopolymersomes. These can then be purified ready for fur-
ther application. This opens up extensive engineering opportunities with respect to MNP/polymersome 
properties for various applications.
Our new approach to the synthesis of magnetopolymersomes permits the creation of a simple bio-
compatible nanoreactor, activated by the application of an electric field for the engineering of precise 
magnetopolymersomes.
Results and Discussion
The amphiphilic block copolymer was synthesized by the polymerization of ethylene oxide (PEO) and 
butadiene (PBD) monomers. PBD (1300)-PEO (2500) was chosen for polymersome synthesis as previous 
studies had shown the production of monodisperse unilamellar vesicles, within the required size range 
for this system24–26. Polybutadiene is a robust non-polar monomer, making it ideal for the electroporation 
process, as it can withstand the application of an electric field without degradation. In contrast the poly-
ethylene oxide is polar, yet biocompatible and widely used to extend the physiological lifetime of several 
biomedical nanoparticles (NPs) and vesicles. Polymersomes were produced simply by rehydration and 
swelling of a polymer film (Methods). PBD-PEO forms vesicles with a bilayer of 4–5 nm (Supplementary 
Figure S1) comparable to a naturally occurring lipid bilayer. Additionally, extrusion was used to explore 
vesicle size control. Transmission electron microscopy (TEM) and Dynamic light scattering (DLS) anal-
ysis were used to characterize both the polymersome size and the sample size distribution (Fig. 2). These 
techniques are complementary: Transmission Electron Microscopy (TEM) of stained non cryo preserved 
samples shows the morphology, degree of aggregation, and sample homogeneity, but staining and drying 
artefacts can result in distortions and an appearance of shrinkage of the vesicles. DLS offers universal 
analysis of the complete sample (accurate population), but as a scattering technique gives the full hydro-
dynamic size, and uses a parameter defined for a perfectly spherical material, which is a not an exact 
match to our polymer or vesicle geometry, both of which contribute to them appearing larger than the 
true polymersome size. Therefore, it should be noted that there is a discrepancy (approximately 2-fold) 
between the DLS and TEM sizing, but importantly the population distribution is in agreement. With 
this in mind, cryo-EM was also performed (Fig. 3) in which the images, which do not suffer the same 
deformations from staining and drying, show a preserved membrane bilayer and a true size slightly larger 
than the stained TEM; however, cryo-EM cannot be performed on the large scale required to obtain a 
size distribution. Importantly, the TEM analysis of the stained sample permitted a rapid and clear assess-
ment that the samples are of high homogeneity and low aggregation. It was found that while extrusion 
produced a close to homogeneous population of 41.2 ± 6.4 nm by TEM (123 ± 26 nm by DLS) it does 
require an extra processing step, which may not be necessary as a simple stirred method yields two pop-
ulations of polymersomes of a similar polydispersity of 100.9 ± 8.6 nm by TEM (203 ± 55 nm by DLS) 
(Fig. 2A), with an additional population around 43 nm by TEM (58 nm by DLS). The polydispersity of 
this stirred sample improves as a matter of course in later processing of the magnetopolymersomes (size 
separation via clean up on the column, Supplementary Figure S2). The similar distribution achieved by 
a simple method such as stirring alone is indicative of the simplicity of this process, further highlighting 
its advantage over other synthetic routes.
We successfully encapsulated a range of different bases of varying ionic strength and 10 mM NaOH 
encapsulated polymersomes (Fig.  2) were found to be the lowest optimal base concentration for an 
instantaneous room-temperature precipitation of MNPs. Below this concentration range heterogeneous, 
mixed crystalline and amorphous iron oxides are precipitated (Supplementary Figure S3). Low ambient 
Figure 2. Characterisation of the polymersomes. Comparison of two different preparation methods of the 
NaOH encapsulated polymersomes; Extruded and stirred. (A) DLS data sizing (B) the corresponding TEM 
grainsizing and (C) TEM image of an extruded polymersome sample (stained with 0.75% uranyl formate) 
(cryo-TEM image of stirred sample shown in Fig. 3A).
www.nature.com/scientificreports/
4Scientific RepoRts | 5:14311 | DOi: 10.1038/srep14311
concentrations of reagents are favoured in keeping with greener routes, as well as ensuring little to no 
effect on the polymersome formation or toxicity in later in vivo use. Moreover, this simple synthetic 
route occurs under ambient conditions, whereas other bases tested (KOH and CO(NH2)2) required sus-
tained heating for MNP formation making them impractical for vesicular MNP precipitation. 10 mM 
base offered the optimal balance between good MNP precipitation and polymersome stability.
When base filled polymersomes were suspended in an iron solution, MNPs did not form, showing that 
the natural permeability of the PBD-PEO membrane was not sufficient to allow the reagents to penetrate 
the membrane (i.e. the base cannot leak out and the iron ions cannot leak in) (Fig. 3A). However when 
these polymersomes were subjected to electroporation (2500 V, 5 Pulses) reagents were able to diffuse 
through the resulting membrane pores and MNPs were formed within the membrane successfully. The 
MNP size analysis showed them to be 2.54 nm in diameter with a tight size distribution (SD ± 0.46 nm) 
(Supplementary Figure S4) at this voltage. Energy dispersive x-ray (EDX) elemental analysis showed the 
particles were iron-oxide species by confirming the presence of iron and oxygen (Supplementary Figure 
S5). Induced coupled plasma emission spectroscopy (ICP-ES) elemental analysis reveals iron compounds 
made up approximately 1.40–1.42% (dependent on mineral type) of the magnetopolymersome (iron: total 
polymer ratio (Supplementary calculation 1)). Magnetic hysteresis measurements reveal the particles to 
be superparamagnetic iron oxide and that MNP magnetic material makes up approximately 0.20–0.23% 
of the magnetopolymersome mass which is comparable but suggests that the iron present may not all 
be magnetic mineral. In order to determine how the MNPs are associated with the membrane cryo-EM 
analysis was employed (Fig. 3) to ensure no preparation artefacts27. Cryo-EM images of unelectroporated 
polymersomes (Fig.  3A) and electroporated magnetopolymersomes (Fig.  3B) showed particles present 
within and associated with the membrane only in cases where electroporation had been applied with 
negligible free particles in the background (Fig. 3). Size analysis of the magnetopolymersomes based on 
the room temperature TEM data showed them to be 47.26 ± 9.29 nm (Fig. 3C, Supplementary Figure S2). 
To further characterize the vesicles and their associated MNPs a tomographic tilt series of the polymer-
some sample was generated allowing for a clearer analysis of both the polymersome membrane and its 
interior, again showing no MNPs in the core of the vesicle (Supplementary Video). The cryo EM images 
(Fig.  3A,B) were obtained 10 months after the sample was prepared as opposed to the TEM image in 
Fig. 3C which was obtained 2 months after preparation, which can explain some of the differences seen 
between the images. After a period of time, any MNPs released as a result of degradation will be attracted 
to the exterior of other magnetopolymersomes which is seen in Fig. 3B. It is noteworthy that the level 
of degradation is very low showing good stability of the magnetopolymersomes over a long time period.
Further to this, a pH analysis was conducted at each stage of the process and showed minimal change 
in pH to the extra-vesicular solution before and after electroporation (Supplementary Figure S6) showing 
all the NaOH is reacted and neutralised during the MNP formation process. Polymersomes were also 
sonicated to disrupt the membranes before and after electroporation. Disruption of base filled polymer-
somes that had not undergone MNP precipitation showed an increase in pH as the NaOH was released. 
This is contrary to the disruption of the magnetopolymersomes, which showed a small lowering of the 
pH. This is further evidence that no NaOH remains inside the interior after electroporation and the small 
difference shows that the insertion of MNPs within the membrane does not alter the integrity of the 
membranes. Importantly, the small pH changes seen are not significant enough to raise toxicity concerns 
for eventual in vivo applications.
A small number of polymersomes can be seen to have smaller polymersomes encapsulated within 
them. From the analysis of these samples it is clear that precipitation of MNPs is limited to within 
the outer membrane, evident by the lack of MNPs within the membrane of the inner polymersome 
(Supplementary Video). This provides further evidence for our hypothesis for the mechanism of precip-
itation presented in Fig. 1. It is also highly advantageous as it leaves the core of the vesicle completely 
free for further functionalization, such as the encapsulation of therapeutics during formation or post 
Figure 3. Analysis of magnetopolymersomes. Single particle cryo-EM images of extruded polymersomes 
before (A) and after (B) electroporation, with the latter displaying a high density of iron particles around the 
membrane. (C) shows the same sample as in (B) as imaged by room temperature TEM.
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formation attachment to the outer PEG monomer. This study has shown that polymersomes can be 
functionalized in situ by a mechanism which can be universally applied to inorganic NP mineralization 
within a nanoreactor.
Magnetic resonance (MR) relaxometry results (at 7 Tesla) for the R2 and R2* rates of our magnetopol-
ymersomes in solution were 22.7 s−1 and 148.8 s−1 respectively (Fig. 4). The R2 relaxivity normalized for 
iron concentration was 9.1 [Fe mM]−1 s−1. Detailed analysis conducted on both magnetopolymersomes 
and unelectroporated polymersomes show a distinct difference in R2 relaxometry, with the addition of 
MNPs in the polymer membrane showing a significantly faster decay with increasing magnetopolym-
ersome concentration (Supplementary Figure S7). The decay of the control unelectroporated polymers 
is comparable to that of the saline control sample confirming that little or none of the contrast shown 
in Fig. 4 is the result of signal decay as the protons diffuse in and around the polymersome membrane. 
Similarly, R2* control data (Supplementary Figure S7) shows enhanced decay with the presence of MNPs, 
although it was not possible to extract a clear relationship between MNP concentration and decay due 
to the very rapid relaxation. It is clear that the precipitation of small superparamagnetic particles within 
the membrane has positive effects; firstly as the precipitation of 2.54 nm particles has a much greater 
surface area than more conventional MNPs of about 20 nm; and secondly on the unavoidable, but often 
useful diffusion effects we see in the R2 decay data. The position of MNPs within the membrane immo-
bilises them in close proximity to the water molecules, essentially creating more random magnetization 
dephasing interactions that cannot be refocused with conventional spin-echo (MR) techniques. The for-
mation method presented here also has the potential to be tuned to give magnetopolymersomes with 
differing numbers and sizes of MNPs by varying a number of parameters (Supplementary figure S8). For 
example, varying the electroporation voltage between 250 V and 2500 V changes the size and number of 
MNPs per polymersome (Supplementary Figure S8a) with larger MNPs forming at lower voltages, and 
an increased R2 relaxivity per mM Fe concentration is seen from 1.3 [Fe mM]−1s−1 to 9.1 [Fe mM]−1s−1 
(Supplementary Figure S8b). We also observe a strange crossover in parameters at 1000 V where we see 
smaller particles in increased number (Figure S8). We are currently trying to understand the mechanism 
by which this occurs and optimize the parameters to tune for the full range of specific MNP sizes and 
MRI signal.
Peters et al.28 measured the grey matter R2* relaxation rate as 30 s−1. This is significantly different 
to the R2* relaxation rate for our vesicles (148.8 s−1) suggesting they could be very promising future 
in vivo biomedical agents; however this will require further dose and toxicity related investigation in a 
pre-clinical setting.
Conclusion
A method has been developed for the in situ formation of superparamagnetic iron oxide NPs within a 
polymersome. The data confirmed that MNP precipitation occurred in the vesicle membrane. We pro-
pose a mechanism (Fig. 1) whereby pores formed by electroporation enable the simultaneous efflux of 
base and influx of iron through the pores to mix the reagents and equilibrate the pH gradient within 
Figure 4. Magnetopolymersomes show enhanced contrast in MRI imaging. 7 T magnetic resonance R2 
relaxometry data (16 echoes, 9 slices, image shows 5th slice) and 7 T magnetic resonance R2* relaxometry 
data (12 echoes, 9 slices, image shows 5th slice). Both R2 and R2* relaxometry rates show significant 
differences between saline (dashes) and electroporated polymersomes (solid).
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the membrane, yielding the crystallization of multiple membrane embedded MNPs templated within 
the pore. The diameter of magnetopolymersomes was shown to be homogeneous by DLS and TEM with 
no signs of aggregation with embedded magnetite MNPs of 2.54 nm in size (Supplementary Figure S4). 
Further optimization of the reactant concentrations should alter the rate of influx and efflux of substances 
across the membrane, due to the basic principles of osmosis and diffusion; this in turn will have the 
potential for further regulation of MNP formation.
The advantages of this method are many: Firstly the simplicity of the whole system. The polymer-
somes are easy to produce in stable narrow-size distribution populations, and the MNPs are produced 
simply in a one-step in situ process. Secondly, the precipitation reaction is a room temperature route that 
offers vast scope for tuning and optimising the material. The method offers flexibility with respect to tun-
ing the number and sizes of the MNPs within the membrane simply by altering the reagent concentration 
and/or the electroporation parameters. Thirdly, the non-specific nature of electroporation offers immense 
flexibility for this method to be developed and optimized for the incorporation of a wide range of inor-
ganic NPs (magnetic or otherwise), from simply doping the MNPs (to tune the magnetic properties) 
to precipitating alternative MNPs such as CoPt or NPs with different properties such as quantum dot 
fluorescent markers. Fourthly, the use of electroporation allows for the remote triggering of MNP pre-
cipitation by application of an electric field. This is hugely advantageous, mainly from a practical point of 
view in that MNPs can be highly sensitive to oxidation and can incur stability problems. Electroporation 
at the point of use delivers the freshest MNPs to ensure the timely delivery of high quality, stable MNPs 
for application, removing shelf-life issues. Additionally, remotely triggering polymersomes to form mag-
netopolymersomes via electroporation can present a host of opportunities in further applications, for 
example, in cases were a magnetic response would be valuable during application both in vivo and in 
vitro such as in the case of iron sensing assays. Fifthly, the structure of the magnetopolymersome in 
which MNPs are located bound within the membrane leaves the vesicle core free for encapsulation 
during formation and subsequent localised release of hydrophilic drugs, showing their great potential as 
therapeutic agents. Finally, our magnetopolymersomes have proved to provide good contrast during MRI 
imaging trials which shows they could prove to be viable for in vivo diagnostic application (following 
further optimization and toxicity studies).
We present a significant first step towards realizing a fully tuneable and remotely switchable ther-
anostic agent, in which MNP formation within a membrane can be controlled in situ by application 
of an electric field. Although the methods presented in this work are specific to iron oxide formation, 
electroporation controlled NP synthesis could open up new methods for a wide range of NP embedded 
polymersome syntheses.
Methods
Polymersome formation. Polymer was purchased from Polymer Source Inc. (Canada) and can 
be synthesised using living anionic polymerisation according to the method previously published by 
Hillmyer et al.24 Polymer species were confirmed by nuclear magnetic resonance (NMR) (Supplementary 
Figure S9). All other reagents were purchased from Sigma Aldrich (UK). Unilamellar vesicles were pre-
pared by dissolution of amphiphilic block copolymer polyethylene oxide-polybutadiene (PBD (1300)-
PEO (2500), 1–4 addition, 10 mg) into chloroform (1 ml). Subsequent evaporation under vacuum at 
room temperature of the solvent resulted in a polymer film across the bottom of the vial which was 
rehydrated with a variety of 10 mM basic solutions to encapsulate a basic core. Three methods were then 
used to form polymersomes. 1. The rehydrated film solution was stirred over 24 hrs. 2. The rehydrated 
film solution was tip sonicated at room temperature for 30 minutes on 50% amplitude. 3. The rehydrated 
film solution was extruded though a filter containing 100 nm pores 15 times.
In situ electroporation of polymersomes. Due to the sensitivity of the iron salt to oxidation, 
all solutions were degassed prior to use and experiments were carried out under an inert atmosphere. 
Polymersomes encapsulating NaOH solution (10 mM) were passed through a Sephadex column contain-
ing Sepharose 4B to remove the basic supernatant to avoid the formation of external precipitation on 
addition of iron solution. Polymersomes at a concentration of approximately 1 mg/ml (as measured by 
gas chromatography (Supplementary Figure S10)) containing NaOH and suspended in PBS buffer were 
added (in a 1 ml 1:1 volume ratio) to an excess volume of mixed valence iron salt solution (containing 
FeCl2.4H2O (10 mM) and FeCl3.6H2O (10 mM) in a 1:2 (v/v) ratio). The solution was electroporated 
(Eppendorf (Eporator), Bio-rad (Multipulser), 5 x at 2500 V pulse length averaging 2.4 ms) in an excess 
of mixed valence iron salt solution to open up pores within the membrane. Following electroporation the 
polymersomes were passed back through a Sephadex column to remove excess iron solution and external 
iron oxide precipitates which were not tightly associated with the polymersome.
Characterisation of Magnetopolymersomes. Polymersome size was initially evaluated using 
dynamic light scattering (Malvern Zetasizer (Zetasizer Nano)). Formation, evidence of encapsulation 
and size analysis was evaluated using transmission electron microscopy (Philips CM200,) as well as 
energy dispersive X-ray analysis for elemental characterisation (Supplementary Figure S5). Cryogenic 
transmission electron microscopy (cryo-EM) was used to directly visualise the resulting polymersomes. 
Grids were prepared by placing 3 μ l of sample onto a glow discharged 300 mesh Lacey carbon grid. 
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The grids were subsequently blotted for 6 seconds (at 100% humidity) and plunged into liquid ethane 
using a Vitrobot mark IV. Samples were visualised on a Tecnai F20 microscope fitted with a Gatan 
4 k × 4 k CCD camera. All data was collected in low dose mode. Single axis tilt series were collected 
using SerialEM29 with an object sampling of 0.44 nm per pixel. Tilt series were collected (from + /− 30o 
for the supplementary movie) at 2o increments using a dose of ~2 e−/Å2. Tilt series were collected at 
~6 μ m defocus. Tilt series were reconstructed by fiducial-less alignment in 3DMOD, part of the IMOD 
package30. Elemental composition of magnetopolymersomes was confirmed with inductively coupled 
plasma emission spectrometry (ICP-ES) by dissolving a magnetopolymersome samples in 1 M nitric 
acid to remove the organic polymer material from around the nanoparticles. This was then related to the 
magnetic saturation of the magnetopolymersomes as measured with room temperature superconducting 
quantum interference (SQUID) magnetometry, on a film of magnetopolymersomes at 1 T (300 K).
In vitro MRI measurements. The inclusion of superparamagnetic nanoparticles within the polym-
ersome membrane makes them ideal candidates for future magnetic resonance (MR) contrast agents or 
traceable in vivo therapeutic transporters. To test the applicability of our magnetopolymersomes, MR 
relaxometry was undertaken to quantify the transverse relaxation rates (R2 & R2*). An Eppendorf con-
taining 1 ml of magnetopolymersomes (of initial concentration of 10 mg/ml polymer before synthesis 
and purification) was placed inside a tube of saline (for improved field shimming purposes) and this 
was placed at the iso-centre of a 7 Tesla magnet (Bruker BioSpec Avance III, 310 mm bore, MRI system 
B/C 70/30). The system used a 660 mT/m imaging gradient set with integrated shimming coils (BGA-12S 
Bruker, Germany). A 1H quadrature resonator (300 MHz, 1 kW max, outer diameter 114 mm/inner diam-
eter 86 mm) was used for both transmission and reception of RF. Transverse relaxation rates, R2 & R2*, 
were measured using a Multi-Spin-Echo and Multi-Gradient-Echo sequence, respectively. Image matrix 
size was 256*256, FOV = 40 mm, slice thickness = 1 mm. Nine slices were taken through the images 
covering the full depth of the Eppendorf. For R2 estimation TR = 2.5 s, minimum TE = 11 ms increasing 
in steps of 11 ms for 16 echoes. For R2* estimation TR = 2.5 s, minimum TE = 3.8 ms increasing in steps 
of 4.8 ms for 12 echoes (excitation flip angle = 60 degrees). Post experiment image data were analysed in 
Matlab (Mathworks). ROIs were selected within the Eppendorf and the saline (control) and the signal 
as a function of echo time was fitted using non-linear-least squares to a simple mono-exponential decay 
function to estimate the relaxation rate.
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